Windtree Therapeutics, Inc. (NASDAQ:WINT) Short Interest Down 84.2% in November

Windtree Therapeutics, Inc. (NASDAQ:WINT) was the target of a large drop in short interest in the month of November. As of November 15th, there was short interest totalling 30,900 shares, a drop of 84.2% from the October 31st total of 195,700 shares. Currently, 0.4% of the company’s shares are sold short. Based on an average daily trading volume, of 1,720,000 shares, the days-to-cover ratio is currently 0.0 days.

Windtree Therapeutics Trading Up 8.2 %

Shares of Windtree Therapeutics stock opened at $0.61 on Friday. The business’s fifty day moving average price is $1.07 and its 200 day moving average price is $3.86. Windtree Therapeutics has a twelve month low of $0.45 and a twelve month high of $22.36. The stock has a market capitalization of $5.33 million, a P/E ratio of -0.04 and a beta of 0.64.

About Windtree Therapeutics

Windtree Therapeutics, Inc, a biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases. The company’s lead product candidate is istaroxime, which is in Phase 2b clinical trial for the treatment of acute decompensated heart failure, as well as for the treatment of early cardiogenic shock.